21 June 2019
LEI No. 213800QIPVTK5ES5UU36
SCAPA GROUP PLC
('the Company')
PDMR Notification
Notification and public disclosure of transactions by persons discharging managerial responsibilities ('PDMR') and persons closely associated with them ('PCA')
Scapa Group plc (AIM: SCPA) today announces that on 20 June 2019, the PDMRs named below were each granted nil cost options, under the Scapa Group plc 2011 Performance Share plan ('PSP'), in respect of the number of ordinary shares of 5p each ('Ordinary Shares') shown alongside their respective names.
Name / Position of PDMR |
Number of Ordinary Shares over which the option is held |
Heejae Chae - Chief Executive Officer |
550,369 |
Oskar Zahn - Chief Financial Officer |
257,985 |
Joseph Doherty - President Healthcare |
218,400 |
Sevan Demirdogen - President and Vice President |
218,400 |
Wendy Baker - Group General Counsel and CoSec |
125,307 |
Sayoung Jung - MD Global Corporate Dev & Strategy |
155,006 |
In accordance with the rules of the PSP, no consideration was paid by the above-named individuals for the option granted to him/her. Each option is subject to, and governed by, the rules of the PSP and the legislation relating to the PSP.
This announcement, including the notifications below, is made in accordance with the requirements of the EU Market Abuse Regulation.
ANNEX
1 |
Details of the person discharging managerial responsibilities / person closely associated
|
|
a) |
Name |
Heejae Chae
|
2 |
Reason for the notification
|
|
a) |
Position / status |
Chief Executive Officer
|
b) |
Initial notification / amendment |
Initial notification
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|
a) |
Name |
Scapa Group plc
|
b) |
LEI
|
213800QIPVTK5ES5UU36 |
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted
|
|
a) |
Description of financial instrument, type of instrument |
Ordinary Shares of 5p each |
|
Identification Code
|
GB0007281198 |
b) |
Nature of the transaction |
Grant of share option
|
c) |
Price(s) and volume(s)
|
550,369 Ordinary Shares Exercise price 0p |
d) |
Aggregated information - Aggregated volume - Price |
n/a |
e) |
Date of the transaction
|
20 June 2019 |
f) |
Place of the transaction
|
London Stock Exchange, AIM |
1 |
Details of the person discharging managerial responsibilities / person closely associated
|
|
a) |
Name |
Oskar Zahn
|
2 |
Reason for the notification
|
|
a) |
Position / status |
Chief Financial Officer
|
b) |
Initial notification / amendment |
Initial notification
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|
a) |
Name |
Scapa Group plc
|
b) |
LEI
|
213800QIPVTK5ES5UU36 |
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted
|
|
a) |
Description of financial instrument, type of instrument |
Ordinary Shares of 5p each |
|
Identification Code
|
GB0007281198 |
b) |
Nature of the transaction |
Grant of share option
|
c) |
Price(s) and volume(s)
|
257,985 Ordinary Shares Exercise price 0p |
d) |
Aggregated information - Aggregated volume - Price |
n/a |
e) |
Date of the transaction |
20 June 2019 |
f) |
Place of the transaction |
London Stock Exchange, AIM |
1 |
Details of the person discharging managerial responsibilities / person closely associated
|
|
a) |
Name |
Joseph Doherty
|
2 |
Reason for the notification
|
|
a) |
Position / status |
President, Healthcare
|
b) |
Initial notification / amendment |
Initial notification
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|
a) |
Name |
Scapa Group plc
|
b) |
LEI
|
213800QIPVTK5ES5UU36 |
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted
|
|
a) |
Description of financial instrument, type of instrument |
Ordinary Shares of 5p each |
|
Identification Code
|
GB0007281198 |
b) |
Nature of the transaction |
Grant of share option
|
c) |
Price(s) and volume(s)
|
218,400 Ordinary Shares Exercise price 0p |
d) |
Aggregated information - Aggregated volume - Price |
n/a |
e) |
Date of the transaction
|
20 June 2019 |
f) |
Place of the transaction
|
London Stock Exchange, AIM |
1 |
Details of the person discharging managerial responsibilities / person closely associated
|
|
a) |
Name |
Sevan Demirdogen
|
2 |
Reason for the notification
|
|
a) |
Position / status |
President and Vice President
|
b) |
Initial notification / amendment |
Initial notification
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|
a) |
Name |
Scapa Group plc
|
b) |
LEI
|
213800QIPVTK5ES5UU36 |
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted
|
|
a) |
Description of financial instrument, type of instrument |
Ordinary Shares of 5p each |
|
Identification Code
|
GB0007281198 |
b) |
Nature of the transaction |
Grant of share option
|
c) |
Price(s) and volume(s)
|
218,400 Ordinary Shares Exercise price 0p |
d) |
Aggregated information - Aggregated volume - Price |
n/a |
e) |
Date of the transaction
|
20 June 2019 |
f) |
Place of the transaction
|
London Stock Exchange, AIM |
1 |
Details of the person discharging managerial responsibilities / person closely associated
|
|
a) |
Name |
Wendy Baker
|
2 |
Reason for the notification
|
|
a) |
Position / status |
Group General Counsel and CoSec
|
b) |
Initial notification / amendment |
Initial notification
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|
a) |
Name |
Scapa Group plc
|
b) |
LEI
|
213800QIPVTK5ES5UU36 |
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted
|
|
a) |
Description of financial instrument, type of instrument |
Ordinary Shares of 5p each |
|
Identification Code
|
GB0007281198 |
b) |
Nature of the transaction |
Grant of share option
|
c) |
Price(s) and volume(s)
|
125,307 Ordinary Shares Exercise price 0p |
d) |
Aggregated information - Aggregated volume - Price |
n/a |
e) |
Date of the transaction
|
20 June 2019 |
f) |
Place of the transaction |
London Stock Exchange, AIM |
1 |
Details of the person discharging managerial responsibilities / person closely associated
|
|
a) |
Name |
Sayoung Jung
|
2 |
Reason for the notification
|
|
a) |
Position / status |
MD, Global Corp Development & Strategy
|
b) |
Initial notification / amendment |
Initial notification
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|
a) |
Name |
Scapa Group plc
|
b) |
LEI
|
213800QIPVTK5ES5UU36 |
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted
|
|
a) |
Description of financial instrument, type of instrument |
Ordinary Shares of 5p each |
|
Identification Code
|
GB0007281198 |
b) |
Nature of the transaction |
Grant of share option
|
c) |
Price(s) and volume(s)
|
155,006 Ordinary Shares Exercise price 0p |
d) |
Aggregated information - Aggregated volume - Price |
n/a |
e) |
Date of the transaction
|
20 June 2019 |
f) |
Place of the transaction
|
London Stock Exchange, AIM |
For further information:
Scapa Group plc:
Wendy Baker +44 (0) 161 301 7400
Company Secretary
Numis Securities Limited: +44 (0) 20 7260 1000
Mark Lander/Richard Thomas
(Joint Broker/Nominated Adviser)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.